Company Medix Biochemica develops, produces and markets monoclonal antibodies, antibody services and recombinant antigens for IVD industry, as well as POC testsfor human healthcare worldwide. MedixMAB Antibodies and MedixAntigens include markers in cardiovascular, diabetes, metabolism, fertility, infectious disease, inflammation, serology, thyroid and tumor fields. MedixMAB Services cover recombinant antibody development, contract manufacturing of antibodies and coating of microplates. Actim rapid tests are easy to use bedside tests e.g. for pregnancy monitoring (detection of membrane rupture and screening for risk of preterm delivery), immunological FOB testing, screening of acute Pancreatitis and acute disease detecting (CRP, Influenza A&B, RSV, Noro).